6861 - 6870 of 8808 Results
Title
Year
-
RESTRICTEDTitle: A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomographyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 12Start Page: 1692End Page: 1695Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26411Citation Count: 23
-
OPENTitle: Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare dataJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 5Start Page: 744End Page: 754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25074Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5812286Citation Count: 45
-
OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6589361Citation Count: 23
-
RESTRICTEDTitle: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentaryJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015Citation Count: 1
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: http://doi.org/10.1002/mds.22781Citation Count: 58
-
OPENTitle: Lesion of the centromedian thalamic nucleus in MPTP‐treated monkeysJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 5Start Page: 708End Page: 715Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.21906Best OA location URL: http://doi.org/10.1002/mds.21906Citation Count: 29
-
OPENTitle: Radiosynthesis, In Vitro Characterization, and In Vivo PET Neuroimaging of [18F]F-4 for Tau Protein: A First-in-Human PET StudyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00866Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00866?ref=article_openPDFCitation Count: 0
-
OPENTitle: Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 652End Page: 654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27280Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5988253Citation Count: 8
-
RESTRICTEDTitle: Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 203Issue #: 2Start Page: 394End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.08.029Citation Count: 79
-
RESTRICTEDTitle: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 621End Page: 639Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1Citation Count: 58